12:00 AM
 | 
Oct 21, 2010
 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Neurology
Rett syndrome Methyl CpG binding protein 2 (MECP2; RTT); microRNA-30a (miR-30a);...

Read the full 177 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >